Generate Biomedicines (GENB)

Generate Biomedicines (GENB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• GENB last traded at $13.22, -8.58% on the day.
• Generate Biomedicines: P/E -7.8, revenue $32.49M over the last four quarters.

Updated 2026-11-02 20:36 UTC